secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-03-20T23:59:59+00:00
Accession:  0001575872-23-000384
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition extends business combination deadline to April 19, 2023; Estrella deposits $45,511
--------------------------------------------------------------------------------

- Estrella Biopharma deposited $45,511 into trust account to extend deadline from March 19 to April 19, 2023.
- Company issued unsecured promissory note to Estrella for $45,511, bearing no interest, payable upon business combination.
- Conversion option: Estrella may convert note into private shares at $10.00 per share, with 30-day lock-up after business combination.
- Monthly extensions available through July 19, 2023, at $0.05 per public share per month.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000384/0001575872-23-000384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000384/uptd-20230303.htm
  HTML page:      https://secwatch.observer/filing/0001575872-23-000384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer